Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial.

Al Salman, Mohammad; Ghiasi, Maryam; Farid, Ali Salehi; Taraz, Mohammad; Azizpour, Arghavan; Mahmoudi, Hamidreza

Al Salman, Mohammad; Ghiasi, Maryam; Farid, Ali Salehi; Taraz, Mohammad; Azizpour, Arghavan; Mahmoudi, Hamidreza.

Afiliación

Al Salman M; Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ghiasi M; Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farid AS; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Taraz M; Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Azizpour A; Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mahmoudi H; Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Dermatol Ther ; 34(5): e15075, 2021 09.

Article en En | MEDLINE | ID: mdl-34327798

Asunto(s)

Psoriasis; Terapia Ultravioleta; Terapia Combinada; Humanos; Psoriasis/diagnóstico; Psoriasis/tratamiento farmacológico; Calidad de Vida; Índice de Severidad de la Enfermedad; Simvastatina/efectos adversos; Resultado del Tratamiento; Terapia Ultravioleta/efectos adversos

Palabras clave

DLQI psoriasis; autoimmunity; narrowband UVB; phototherapy; psoriasis; psoriasis area and severity index; simvastatin; statins

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Psoriasis / Terapia Ultravioleta Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google